Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy

Journal of Thoracic and Cardiovascular Surgery

Volumn 132, Issue 3, 2006, Pages 549-555

  Reynolds, John V ^a   Ravi, Narayanasamy ^a   Hollywood, Donal ^a   Kennedy, M John ^a   Rowley, Suzanne ^a   Ryan, Aoife ^a   Hughes, Niall ^a   Carey, Michael ^a   Byrne, Patrick ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CHYLOTHORAX; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG FATALITY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HOSPITAL PATIENT; HUMAN; IDIOPATHIC DISEASE; KIDNEY DYSFUNCTION; LOWER ESOPHAGUS SPHINCTER; LUNG EMBOLISM; MALE; MORBIDITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION EXPOSURE; RESPIRATORY FAILURE; RISK FACTOR; SEPSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL RISK; SURVIVAL TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SEPSIS;

EID: 33747763374     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.05.015     Document Type: Article

References (30)

1. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 349 (2003) 2241-2252
2. Daly J.M. Esophageal cancer. results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg 190 (2000) 562-572
3. Blot W.J., De Vesa S.S., Kneller R.W., and Fraumeni Jr. J.F. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. JAMA 265 (1991) 1287-1289
4. Pera M., Cameron A., Trastek V., Carpenter H., and Zermeister A. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
5. Altorki N., Kent M., Ferrara R.N., and Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236 (2002) 177-183
6. Lerut T., Coosemans W., De Leyn P., et al. Reflections on 3-field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. HepatoGastroenterology 46 (1999) 717-725
7. Siewert J.R., Stein H.J., Feith M., et al. Histologic tumor type is an independent prognostic parameter in esophageal cancer. lessons from more than 1000 consecutive resections at a single centre in the western world. Ann Surg 232 (2001) 94-103
8. Kelsen D.P., Ginsberg R., Pajak T.F., et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339 (1998) 1974-1984
9. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer. a randomised controlled trial. Lancet 359 (2002) 1727-1733
10. Nygard K., Hagen S., Hansen H.S., et al. Preoperative radiotherapy prolongs survival in operable esophageal cancer: a randomised, multicenter study of pre-operative radiotherapy and chemotherapy: the second Scandinavian trial in esophageal carcinoma. World J Surg 16 (1992) 1104-1110
11. Le Prise E., Etienne P.L., Meunier P., et al. A randomised study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73 (1994) 1179-1184
12. Walsh T., Noonan N., Hollywood D., Kelly A., Keeling N., and Hennessy T.P.J. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
13. Bosset J.-F., Gignoux M., Tiboulet J.-P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
14. Urba S.G., Orriner M.B., Turrisi A., Iannettoni M., Forastiere A., and Strawderman M. Randomised trial of preoperative chemoradiotherapy versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19 (2001) 305-313
15. Law S., Kwong D., Tung H., et al. Preoperative chemoradiation for squamous cell esophageal cancer. a prospective randomised trial. Can J Gastroenterol 12 Suppl B (1998) 56B [abstract]
16. Burmeister B.H., Smithers B.M., Gebski V., et al. Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the oesophagus. a randomised controlled phase III trial. Lancet Oncol 6 (2005) 659-668
17. Siewert J.R., and Stein H.J. Classification of adenocarcinoma of the oesophago-gastric junction. Br J Surg 85 (1998) 1457-1459
18. Bone R.C., Sibbald W.J., and Spring C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101 (1992) 1481-1483
19. Earlam R., and Cunha-Melo J.R. Oesophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 67 (1980) 381-390
20. Muller J.M., Erasmi H., Stelzner M., Zieren U., and Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 77 (1990) 845-847
21. Jamieson G.G., Mathew G., Ludeman R., Wayman J., Myers J.C., and Devitt P.G. Postoperative mortality following esophagectomy and problems in reporting its rate. Br J Surg 91 (2004) 943-997
22. Bailey S.H., Bull D.A., Harpole D.H., et al. Outcomes after esophagectomy. a ten-year prospective cohort. Ann Thorac Surg 75 (2003) 217-222
23. McCulloch P., Ward J., and Tekkis P. Mortality and morbidity in gastro-oesophageal cancer surgery. initial results of ASCOT multicentre prospective study. BMJ 327 (2003) 1192-1197
24. Van Lanschot J.J., Hulscher J.B., Bueskens C.J., et al. Hospital volume and hospital mortality for esophagectomy. Cancer 91 (2001) 1574-1578
25. Begg C.B., Cramer L.D., Hoskins W.J., and Brennan M.F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 280 (1998) 1747-1751
26. Fiorica F., DiBona D., Schepis F., et al. Preoperative chemoradiotherapy for oesophageal cancer. a systematic review and meta-analysis. Gut 53 (2004) 925-930
27. Lee H.K., Vaporciyan A.A., Cox J.D., et al. Postoperative pulmonary complications after preoperative chemoradiation therapy for esophageal carcinoma. correlation with dose-volume histogram parameters. Int J Oncol Biol Phys 57 (2003) 1317-1322
28. Heidecke C.D., Weighardt H., Feith M., et al. Neoadjuvant treatment of esophageal cancer. immunosuppression following combined radiochemotherapy. Surgery 132 (2002) 495-501
29. Horwitz R.I., Viscoli C.M., Clemens J.D., and Sadock R.T. Developing improved observational methods for evaluating therapeutic effectiveness. Am J Med 89 (1990) 630-638
30. Coleman C.N., Stone H.B., Moulder J.E., and Pellmar T.C. Modulation of radiation injury. Science 304 (2004) 693-694